Friday 6 November 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.

Revenue: +4.13%
EPS: −21.7%
Free cash flow: −63.7%

Quarter to September 2026, against a year earlier

564.88 43.61 −7.17%

Follow UTHR

Alert me

Market cap: $24.3B
P/E: 19.7×
Fwd P/E: 22.5×
Dividend yield: —
F-score: 8/9
Altman Z: 19.55
Beneish M: −2.26
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

United Therapeutics Corporation (UTHR) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, United Therapeutics Corporation (UTHR) trades at a P/E ratio of 19.7×. Over the past ten years it has ranged from 0.0× (March 2020) to 48.4× (July 2015); the current reading is higher than 91% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 20.5× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/UTHR/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="United Therapeutics Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/UTHR/metrics/pe-ratio">United Therapeutics Corporation (UTHR) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	16.1×	21.03%
FY2024	13.3×	23.57%
FY2023	10.8×	(36.77%)
FY2022	17.1×	(16.33%)
FY2021	20.4×	56.60%
FY2020	13.0×	—
FY2019	0.0×	—
FY2018	8.0×	(49.57%)
FY2017	15.9×	78.62%
FY2016	8.9×	(18.95%)

Period	P/E ratio	Change
Sep 2026	18.9×	5.86%
Jun 2026	17.9×	(11.52%)
Mar 2026	20.2×	25.27%
Dec 2025	16.1×	9.80%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 48.4×

Ten-year median 12.1×

Current reading's percentile 96

Company	P/E ratio
VTRS Viatris Inc. compare	n/m
ELAN Elanco Animal Health Incorporated compare	n/m
ZTS Zoetis Inc. compare	13.4×
UTHR United Therapeutics Corporation	19.7×
HLN Haleon PLC Sponsored ADR compare	20.5×
NBIX Neurocrine Biosciences, Inc. compare	23.0×
TAK Takeda Pharmaceutical Co. compare	32.0×
RDY Dr. Reddy's Laboratories Ltd compare	44.4×
TEVA Teva Pharmaceutical Industries Ltd. compare	92.6×
Drug Manufacturers Specialty & Generic industry median	20.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

United Therapeutics Corporation (UTHR) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on UTHR

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on UTHR

Stockrow Weekly